Skip to main content

Table 1 β-catenin and BRAF mutational status of tumor and age of 15 ACP patient cohort used in transcriptome study

From: Identification of targets for rational pharmacological therapy in childhood craniopharyngioma

UPN β-Catenin BRAF Age at Dx
411 S33F WT 2
463 S37F WT 4
598 S37C WT 18
646 D32N WT 7
673 S37F WT 2
740 S33F WT 12
802 WT WT 7
883 WT WT 6
956 S37C WT 9
980 D32N WT 13
1000 S45F WT 0
9109 WT WT 9
9201 T41I WT -
9202 T41I WT -
9302 WT WT -